达普托米辛诱导的高胆血症:一个病例报告和机制的简要描述
Praveen Errabelli1, Maulik Lathiya2, Sasmit Roy3
1Nephrology Department Mayo Clinic Health Systems Eau Claire Wisconsin USA.
低剂量达普托米辛可以在没有拉布多解的情况下引起高卡利米亚. 监测电解质和肌酸激酶对于早期检测和预防服用达普托米辛的患者的不良事件至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 高血症是一种关键的电解质失衡,需要及时诊断和管理.
- 达普托米辛是一种抗生素,很少与高血症有关,通常在高剂量时会导致狂犬病溶解.
更多相关视频
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Acute Kidney Injury V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Desensitization and Tachyphylaxis
